Sigba, Danilo G.

HRN: 03-04-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2022
CEFTRIAXONE 1G (VIAL)
11/19/2022
11/25/2022
IV
2g
Q24
UTI
Waiting Final Action 
11/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/20/2022
11/27/2022
IVTT
500mg
Q8
Pus Cells On Stool With Amoeba
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: